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Abstract
Soon after the introduction of the modern prosthetic 
joint, it was recognized that radionuclide imaging pro-
vides useful information about these devices. The bone 
scan was used extensively to identify causes of pros-
thetic joint failure. It became apparent, however, that 
although sensitive, regardless of how the images were 
analyzed or how it was performed, the test was not 
specific and could not distinguish among the causes of 
prosthetic failure. Advances in anatomic imaging, nota-
bly cross sectional modalities, have facilitated the diag-
nosis of many, if not most, causes of prosthetic failure, 
with the important exception of infection. This has led 
to a shift in the diagnostic paradigm, in which nuclear 
medicine investigations increasingly have focused on 
diagnosing infection. The recognition that bone scin-
tigraphy could not reliably diagnose infection led to the 
development of combined studies, first bone/gallium 
and subsequently leukocyte/bone and leukocyte/mar-
row imaging. Labeled leukocyte imaging, combined 
with bone marrow imaging is the most accurate (about 
90%) imaging test for diagnosing joint arthroplasty 
infection. Its value not withstanding, there are signifi-
cant disadvantages to this test. In-vivo  techniques for 
labeling leukocytes, using antigranulocyte antibodies 
have been explored, but have their own limitations and 
the results have been inconsistent. Fluorodeoxyglucose 
(FDG)-positron emission tomography (FDG-PET) has 
been extensively investigated for more than a decade 
but its role in diagnosing the infected prosthesis has yet 
to be established. Antimicrobial peptides bind to bac-
terial cell membranes and are infection specific. Data 
suggest that these agents may be useful for diagnosing 
prosthetic joint infection, but large scale studies have 
yet to be undertaken. Although for many years nuclear 
medicine has focused on diagnosing prosthetic joint 
infection, the advent of hybrid imaging with single-
photon emission computed tomography (SPECT)/elec-
tronic computer X-ray tomography technique (CT) and 
the availability of fluorine-18 fluoride PET suggests that 
the diagnostic paradigm may be shifting again. By pro-
viding the anatomic information lacking in conventional 
radionuclide studies, there is renewed interest in bone 
scintigraphy, performed as a SPECT/CT procedure, for 
detecting joint instability, mechanical loosening and 
component malpositioning. Fluoride-PET may provide 
new insights into periprosthetic bone metabolism. The 
objective of this manuscript is to provide a comprehen-
sive review of the evolution of nuclear medicine imag-
ing of joint replacements.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: Advances in anatomic imaging, notably cross 
sectional modalities, have facilitated the diagnosis of 
many, if not most, causes of prosthetic failure, with the 
important exception of infection. This has led to a shift 
in the diagnostic paradigm, in which nuclear medicine 
investigations increasingly have focused on diagnos-
ing infection. This article is a comprehensive review of 
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the evolution of nuclear medicine imaging of joint re-
placements. In addition to conventional planar imaging 
studies such as bone, gallium, and labeled leukocyte 
imaging, single-photon emission computed tomogra-
phy/electronic computer X-ray tomography technique 
and positron emission tomography imaging with 18F-
fluorodeoxyglucose and 18F (NaI) are covered.
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INTRODUCTION
Contemporary joint arthroplasty procedures began less 
than 75 years ago, when the predecessor of  the modern 
day hip replacement was introduced. A total hip arthro-
plasty includes both femoral and acetabular compo-
nents; a hemiarthroplasty consists of  only the femoral 
component. These prostheses are anchored to bone by 
various methods including polymethylmethacrylate and 
osseous ingrowth into the device’s surface. Some devices 
are coated with hydroxyapatite which induces new bone 
formation and attaches to newly produced periprosthetic 
osseous tissue. The acetabular component can be forced 
into the acetabulum or secured by screws[1]. 
The predecessor of  the contemporary knee prosthe-
sis, developed about 40 years ago, consisted of  a metallic 
femoral component, together with plastic patellar and tib-
ial components. Today’s devices provide improved range 
of  motion and greater durability of  the components[1].
The vast majority of  lower extremity joint replace-
ment surgeries are successful; complications like infec-
tion, fracture, dislocation, and heterotopic ossification are 
uncommon. At the present time the most common cause 
of  prosthetic failure is aseptic loosening, which develops 
in more than a quarter of  these devices and frequently 
results from an inflammatory reaction instigated by pros-
thetic components[2,3]. The debris created by component 
breakdown activates and draws surrounding leukocytes, 
triggering secretion of  cytokines and enzymes damaging 
osseous tissues and leading to prosthetic loosening. The 
cellular response is characterized by an influx of  vari-
ous types of  leukocytes. Neutrophils, however, rarely are 
present[4-6]. Most cases of  aseptic loosening are treated 
with one surgery, the single stage exchange arthroplasty.
Infection, which occurs in up to 2% of  primary 
implants, and up to 5% of  revision implants is an un-
common complication of  prosthetic joint surgery. Risk 
factors for infection include operative suite characteris-
tics, surgical complexity, condition of  the osseous tissue 
surrounding the prosthesis, and immune status of  the 
patient. 
Bacteria bind to most joint replacement components 
and once attached they secrete a protective biofilm[3]. Or-
ganisms commonly encountered in infected joint replace-
ments include Staphylococcus epidermidis and Staphylococcus 
aureus. Streptococcus viridans, Escherichia coli, Enterococcus fae-
calis, and group-B Streptococcus are occasionally identified[4]. 
Early prosthetic joint infections occur by three months 
after implantation, while delayed infections develop 
within three months to one year after implantation. Late 
infections are defined as infections that occur more than 
one year after surgery. Early and delayed infections are 
thought to be due to organisms introduced at surgery; 
late infections are more likely to be due to hematogenous 
spread[7]. 
The infected joint replacement is accompanied by an 
inflammatory reaction characterized by a neutrophilic re-
sponse, often intense[6]. Management of  the infected joint 
replacement consists of  removal of  the device, a lengthy 
course (weeks to months) of  antibiotic treatment, and 
eventually a reimplantation procedure[8].
The correct therapeutic approach often depends on 
the accurate differentiation of  aseptic loosening and in-
fection. This differentiation is not always obvious. Signs 
and symptoms, except for pain, frequently are lacking. 
Laboratory tests may be suggestive, but are not diagnos-
tic, of  infection. Joint aspiration with culture, the defini-
tive preoperative test is specific, but sensitivity is vari-
able[9,10]. Plain radiographs are not specific and prosthesis 
related artifacts limit, to some degree, cross sectional 
imaging studies. 
Nuclear medicine procedures have, for many years, 
contributed useful information about the painful joint 
replacement. This manuscript is a comprehensive review 
of  the evolution of  nuclear medicine imaging of  joint 
replacements.
LITERATURE SEARCH
An electronic search with no language restrictions was 
conducted in the bibliographic database PubMed using 
the terms infection, osteomyelitis, arthroplasty, joint re-
placement, prosthetic joint, bone scintigraphy, bone mar-
row scintigraphy, gallium, labeled leukocytes, besilesomab, 
sulesomab, sulfur colloid, antimicrobial peptides, positron 
emission tomography, positron emission tomography 
(PET), fluorodeoxyglucose (FDG), fluoride and 18F. The 
list of  articles generated was augmented by crosschecking 
the reference lists of  the retrieved papers. This was de-
signed as a comprehensive review, not a meta analysis, of  
the failed joint replacement and therefore neither specific 
inclusion criteria nor any evidence based quality assess-
ment tools were used to select the included articles. 
RADIONUCLIDE IMAGING
Bone scintigraphy 
The first, and undoubtedly the most extensively inves-
tigated, radionuclide procedure used for imaging joint 
arthroplasties was bone scintigraphy. Technetium-99m 
(99mTc) labeled diphosphonates, usually methylene di-
Palestro CJ. Nuclear medicine and the failed joint replacement
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phosphonate (MDP), are used for this study. Radiophar-
maceutical incorporation into the bone depends on per-
fusion and rate of  new bone formation. Imaging usually 
is performed two to fours after injection. The procedure 
also can be performed as a three phase bone scan: the 
flow or perfusion phase, acquired immediately after ra-
diopharmaceutical injection, followed immediately by the 
soft tissue or blood pool phase. The third, or bone, phase 
is performed between two and four hours later.
Gelman et al[10] reported that bone scintigraphy was 
85% accurate for prosthetic hip loosening. Weiss et al[11] 
reported that bone scintigraphy accurately identified 
prostheses requiring surgical intervention. Another group 
of  investigators, however, observed that bone scintigra-
phy cannot determine the cause of  the failure, informa-
tion critical to patient management[12]. 
In an effort to enhance its specificity, investigators 
have studied periprosthetic uptake patterns on bone 
scans. Williamson et al[13] suggested that focal peripros-
thetic uptake indicated loosening and diffuse uptake indi-
cated infection (Figures 1, 2A). Williams et al[14] reported 
that diffuse periprosthetic uptake was sensitive (100%), 
but not specific (54%) for infection. Another group of  
investigators came to the opposite conclusion: diffuse 
periprosthetic uptake was specific, but not sensitive, for 
infection[15]. Aliabadi et al[16] reported that bone scintig-
raphy did not differentiate septic from aseptic loosening 
(Figure 3A). 
Further confounding the analysis of  periprosthetic 
uptake is the numerous uptake patterns present around 
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Figure 1  Aseptically loosened right hip arthroplasty. A: 
X-ray reveals medial protrusion of the acetabular component 
of a painful 15 year old hip replacement. There is heterotopic 
ossification around both greater trochanters (arrows); B: 
On the 99mTc-methylene diphosphonate bone scan, there is 
focally increased radiopharmaceutical accumulation at the 
distal tip of the femoral component (arrow) of the right hip 
replacement and lateral to the femoral neck (arrowhead) 
corresponding to the heterotopic bone seen on the X-ray. 
An aseptically loosened prosthesis was revised. Focally 
increased radiopharmaceutical accumulation is present at 
the tip of the femoral component of the asymptomatic left hip 
arthroplasty (double arrows) which also was 15 years old.
A B
Figure 2  Infected right hip arthroplasty. A: On the 99mTc-methylene diphosphonate bone scan, there is irregularly increased radiopharmaceutical accumulation 
around the entire femoral component of the 2 years old cementless (revision) prosthesis, a pattern which some investigators have reported as specific for infection; 
B-D: On the 99mTc-MDP bone scan, there is diffuse hyperperfusion, and hyperemia around the prosthesis on the flow and blood pool images, and diffusely increased 
periprosthetic radiopharmaceutical on the delayed, bone image (same patient illustrated in Figure 2A); B: Flow; C: Blood pool; D: Bone.
A B
DC
tive study was not reliable for diagnosing either loosening 
or infection. Complicating matters further is the paucity 
of  data on radionuclide bone imaging of  hybrid and bi-
polar prostheses.
Assessment of  knee replacements also is challeng-
ing. In one investigation periprosthetic activity was seen 
around more than sixty percent of  femoral components 
and nearly 90% of  tibial components of  asymptomatic 
devices for up to several years[22] (Figure 4). In an inves-
tigation of  asymptomatic knee replacements with serial 
bone scans periprosthetic activity generally diminished 
over time after implantation. There was considerable 
variation among patients. The authors stated, in order to 
determine the significance of  periprosthetic activity, se-
rial scans need to be performed[23] (Figure 5A). Another 
group of  investigators reported that bone scintigraphy 
does not accurately diagnose the infected knee arthro-
plasty[24]. 
Performing radionuclide bone imaging as a three-
phase study has been advocated to enhance its specific-
ity[25]. Nagoya et al[26] reported that the test was 88% sensi-
tive and 90% specific for hip replacement infection. Most 
other investigations, however, have reported low sensitiv-
ity, low specificity, or both[24,27-30] (Figures 2B and 3B).
Regardless of  how bone scintigraphy is performed, its 
accuracy for diagnosing complications of  lower extremity 
joint prostheses is about 50%-70%. At the present time 
this test is used primarily for screening purposes. A nor-
asymptomatic devices. For up to 12 m after insertion of  
a hip prosthesis, periprosthetic uptake is very variable; 
after this time ten percent of  asymptomatic cemented 
hip prostheses still demonstrate uptake[17]. Increased peri-
prosthetic uptake is even more frequent in cementless 
devices[18-20]. 
Gallo et al[21] studied 27 hydroxyapatite coated hip re-
placements, observing that while a normal study excluded 
aseptic loosening with a high degree of  certainty, a posi-
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Figure 3  Aseptically loosened left hip replacement. A: On the 99mTc-MDP bone scan, there is diffusely increased radiopharmaceutical accumulation around the 
femoral component of the cemented 2 years old prosthesis. Compare with Figure 2A; B-D: On the 99mTc-MDP bone scan, there is diffuse hyperperfusion, and hyper-
emia around the prosthesis on the flow and blood pool images, and diffusely increased periprosthetic radiopharmaceutical on the delayed, bone image (same patient 
illustrated in Figure 3A), B: Flow; C: Blood pool; D: Delayed. The scan appearance is nearly identical to that of the infected prosthesis in Figure 2B.
Figure 4  Asymptomatic right knee arthroplasty. On the 99mTc-MDP bone 
scan, there is irregular, intense radiopharmaceutical accumulation around the 
long stemmed tibial component of a three year old right knee replacement. The 
femoral component is unremarkable. The patient had a history of breast carci-
noma and bone scintigraphy was performed as part of a routine evaluation for 
metastatic disease. 
mal study makes it very unlikely that the patient’s symp-
toms are related to the prosthesis (Figure 6).  
Gallium scintigraphy
Over the years various techniques designed to overcome 
the limitations inherent in bone scintigraphy have been 
investigated. One of  the earliest was gallium-67 citrate 
(gallium) imaging. Gallium uptake in infection likely is 
due to several factors including increased blood flow and 
vascular membrane permeability at inflammatory sites, 
lactoferrin binding and siderophore and bacterial uptake 
of  gallium. Some gallium may be transported by leuko-
cytes. Imaging typically is performed two to three days 
after injection[31]. 
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Figure 5  Aseptically loosened right knee 
arthroplasty. A: On the 99mTc-methylene di-
phosphonate (MDP) bone scan, performed 
about 6 mo after implantation (left), shows 
mildly increased radiopharmaceutical accu-
mulation around the femoral and tibial com-
ponents. On the repeat study, performed 9 
mo later (15 mo after implantation), there 
is intensely increased radiopharmaceuti-
cal accumulation around the tibial com-
ponent, while activity around the femoral 
component has resolved. An aseptically 
loosened tibial component was revised; B: 
On the 99mTc-MDP bone scan (left) there is 
increased radiopharmaceutical accumula-
tion around the tibial component of both the 
symptomatic right and asymptomatic left 
knee prostheses. There is normal peripros-
thetic distribution around both prostheses 
on the gallium-67 image (right), and the 
combined study is negative for infection; C: 
On the 99mTc-MDP bone scan (left) there is 
increased radiopharmaceutical accumula-
tion around the tibial component of the 
symptomatic right and faintly increased 
accumulation around the tibial component 
of the asymptomatic left knee prosthesis. 
On the gallium-67 image (right), in contrast 
to the bone scan, there is increased radio-
pharmaceutical accumulation around the 
femoral component (arrows) of the right 
knee replacement, while activity around the 
tibial component is normal. There is normal 
periprosthetic gallium activity around the as-
ymptomatic left prosthesis. The distribution 
of activity around the right knee prosthesis 
on the bone and gallium studies is spatially 
incongruent and the combined study is 
(false) positive for infection. Aseptic loosen-
ing of joint replacements often is accompa-
nied by an intense inflammatory response 
and gallium cannot reliably differentiate 
infection from inflammation.
Figure 6  Normal 99mTc-methylene diphosphonate 
bone scans of bilateral hip (left) and right knee (right) 
prostheses. A normal bone scan is defined as a scan in 
which periprosthetic activity is indistinguishable from adja-
cent, non-articular bone. The bone scan has a high nega-
tive predictive value and therefore a normal study makes 
it very unlikely that the patient’s symptoms are related to 
the prosthesis.
Reing et al[32] observed that bone scintigraphy was 
sensitive (100%), but not specific (15%), while gallium 
was sensitive (95%) and specific (100%). Other investiga-
tors have reported similar results[15,33,34]. Aliabadi et al[16], in 
contrast, found, for the infected hip replacement, gallium 
scintigraphy was specific (100%) but insensitive (37%). 
While some investigators have evaluated gallium im-
aging alone, other investigators have interpreted bone 
and gallium imaging together. Standardized criteria for in-
terpretation of  the combined study have been developed. 
The test is positive for osteomyelitis when distribution 
of  the two tracers is different or, when their distribution 
is the same and the relative intensity of  gallium uptake 
exceeds that of  the bone agent. The test is equivocal for 
osteomyelitis when the distribution of  the two radiotrac-
ers is the same, both spatially and in intensity. The test is 
negative for osteomyelitis when the gallium images are 
normal, regardless of  the bone scan findings, or, when 
the distribution of  the two tracers is the same and the 
relative intensity of  gallium uptake is less than that of  the 
bone agent (Figure 5B and 5C)[1].
Tehranzadeh et al[35] reported that  bone/gallium im-
aging was 95% accurate for prosthetic joint infection. In 
most other series the test has been less successful. In 30 
patients the test identified only 50% of  the infected joint 
replacements[14]. Gómez-Luzuriaga et al[36] found that 
bone/gallium imaging was 80% accurate for prosthetic 
joint infection. Kraemer et al[37] reported that the com-
bined test was 38% sensitive, and 100% specific for hip 
replacement infection. Merkel at al[38,39] evaluated bone/
gallium imaging in an animal investigation and in patients 
and reported similar results. 
Over the years the use of  gallium for joint replace-
ment infection has declined, and it has been replaced in 
most circumstances by labeled leukocyte imaging. 
Labeled leukocyte scintigraphy
The accumulation of  in-vitro labeled white cells at a site 
of  infection depends on chemotaxis, the quantity and 
sorts of  leukocytes labeled, and the primary cellular re-
sponse in a particular situation. Neutrophils usually com-
prise the majority of  leukocytes labeled and consequently 
sensitivity of  WBC imaging is highest for neutrophil-
mediated inflammatory processes[40]. When indium-111 is 
the radiolabel, images are acquired 18-30 h after adminis-
tration. When technetium-99m is the radiolabel, imaging 
usually is performed four to six and repeated 18 to 30 h 
after administration. 
One would anticipate that, because neutrophils invari-
ably are present labeled leukocyte (WBC) imaging would 
accurately diagnose prosthetic joint infection. Interesting-
ly, for quite some time, the value of  the test was a subject 
of  controversy. 
In a canine study, Merkel et al[38] reported that WBC 
imaging was 94% sensitive and 86% specific for pros-
thetic infection. Pring at al[41] found that WBC imaging 
was 100% sensitive and 89.5% specific for the infected 
prosthetic joint. In another investigation, Pring et al[42] 
observed that WBC activity around infected prostheses 
was always significant. Rand et al[43] found that sensitivity 
and specificity for prosthetic knee infection was 83% and 
85% when moderately to markedly increased peripros-
thetic activity was present. Magnuson et al[27], in an inves-
tigation of  98 patients reported sensitivity and specificity 
for WBC imaging of  88% and 73% respectively, for 
lower extremity joint replacement infection. 
In some studies, WBC imaging was specific, but not 
sensitive for prosthetic joint infection, while in others the 
test was sensitive but not specific[15,34,44,45]. 
Poor sensitivity has been ascribed to the chronicity 
of  the process; i.e., presumably the neutrophilic response 
had ceased, or at least waned, by the time the patient un-
derwent imaging. Neutrophils, however, almost always are 
present in the infected joint replacement, regardless of  
the duration of  symptoms, so chronicity does not explain 
low sensitivity. 
Poor specificity often has been attributed to non-
specific inflammation. It was thought that false positive 
results were secondary to labeled leukocyte accumulation 
in aseptic inflammation. Although aseptic inflammation 
around a prosthetic joint replacement is often accompa-
nied by an intense leukocyte response, neutrophils rarely 
are present. In most situations, primarily neutrophils are 
labeled and the sensitivity of  WBC imaging is greatest 
for detecting infections characterized by a neutrophilic 
response. The test is not at all sensitive, however, for de-
tecting inflammation that is not neutrophil mediated[40]. 
Given the lack of  a neutrophilic response in the asepti-
cally inflamed prosthesis, inflammation cannot be the 
sole explanation for poor specificity. 
What is the reason for the variable and often contra-
dictory observations? WBC images usually are interpreted 
by comparing intensity of  periprosthetic uptake to inten-
sity of  uptake in some predefined reference point, typi-
cally an area of  presumably normal bone marrow. Studies 
in which intensity of  labeled leukocyte activity in the area 
of  interest exceeds intensity of  activity in the reference 
point are classified as positive for infection; otherwise the 
study is negative. The likelihood of  infection, however, is 
not related to intensity of  periprosthetic activity (Figures 
7A and 8A). In one investigation[46] the accuracy of  the 
test varied with the manner in which the studies were 
interpreted. The mere presence of  periprosthetic activ-
ity, regardless of  intensity, was 100% sensitive and 23% 
specific. Using periprosthetic activity exceeding activity in 
the contralateral extremity as the criterion for infection, 
sensitivity was 65%, specificity was 61%[46].
There is another problem inherent in the inter-
pretation of  WBC images. Leukocytes, labeled or 
otherwise, accumulate in bone marrow, the normal 
distribution of  which can be variable. Generalized, as 
well as localized, marrow expansion alter the “normal” 
distribution of  marrow making it difficult to differentiate 
labeled leukocyte uptake in unusually located, but normal, 
marrow from uptake in infection[47].
In a manner analogous to bone/gallium imaging, it 
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has been suggested that interpreting WBC images togeth-
er with bone scans improves results. In one study, WBC 
imaging alone was 45% specific for prosthetic joint in-
fection, but improved to 85% with the addition of  bone 
imaging[44]. Johnson et al[45] observed that the combined 
test was more specific and only slightly less sensitive than 
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Figure 7  Infected left hip arthroplasty. A: On this anterior image from an indium-111 labeled leukocyte study, periprosthetic activity (arrows) is similar in intensity 
to activity in the contralateral lower extremity and less intense than pelvic activity, areas typically used as reference points when interpreting these studies. Because 
studies in which the intensity of labeled leukocyte activity in the region of interest does not exceed intensity of activity in the reference point, this study could be er-
roneously interpreted as negative for infection; B: The distribution of periprosthetic activity on the labeled leukocyte (left, 111In-WBC) and sulfur colloid bone marrow 
(right, 99mTc-SC) images is spatially incongruent (arrows), i.e., there is activity in the left hip joint on the labeled leukocyte image, but not on the bone marrow image. 
The combined study is positive for infection. (Same patient illustrated in Figure 7A); Although the planar combined indium labeled leukocyte/bone marrow study (C, 
left, 111In-WBC; right, 99mTc-SC) is positive for infection (arrows), precise information about the location and extent of infection is lacking. On the fused images (bottom 
row) from the labeled leukocyte SPECT/CT (D) the location of the abnormal labeled leukocyte accumulation (arrows) can clearly be seen adjacent and extending to 
the prosthesis at the level of the greater trochanter. Note also the adjacent hypodense area in the soft tissues, consistent with abscess. Bone marrow SPECT/CT im-
ages (E) acquired simultaneously with the labeled leukocyte images in 16a confirm that the activity on the labeled leukocyte component of the examination is due to 
infection. Whether or not the bone marrow component of the SPECT/CT study contributes additional information beyond what planar imaging provides remains to be 
determined.
CT coronals
NM coronals
CT sagittals
NM sagittals NM transaxials
CT transaxials CT coronals
NM coronals
CT sagittals
NM sagittals NM transaxials
CT transaxials
WBC imaging for hip replacement infection. 
Palestro et al[24] observed that the addition of  bone 
imaging did not increase the accuracy of  WBC imaging 
for knee arthroplasty infection. In another investigation, 
the accuracy of  the combined test for lower extremity 
joint replacement infection was only 76%[48]. In an inves-
tigation of  patients with asymptomatic cementless hip 
replacements, using standard interpretive criteria, WBC/
bone imaging would have been classified as positive for 
infection 15% of  the time[18]. 
Another approach to WBC imaging of  the prosthetic 
joint is to combine the test with bone marrow imaging, 
which usually is performed with 99mTc sulfur colloid. Both 
radiopharmaceuticals accumulate in the reticuloendothe-
lial cells of  the bone marrow. The distribution of  marrow 
activity on WBC and bone marrow images parallel one 
another in most situations. The one exception is osteo-
myelitis, in which the distribution of  these two agents 
differs, i.e., the images are spatially incongruent (Figures 
7B and 8B)[47].
Mulamba et al[49] reported 92% sensitivity and 100% 
specificity for prosthetic hip infection. Palestro et al[24,46] 
reported similar results for infected hip and knee ar-
throplasties. Love et al[50] studied 59 lower extremity joint 
prostheses and reported that WBC/marrow imaging was 
95% accurate for infection. El Espera et al[51] reported 
91% accuracy for lower extremity prosthetic joint infec-
tion.
Virtually all of  the investigations published to date 
indicate that WBC/marrow imaging is specific for joint 
replacement infection. In most of  the investigations the 
test has proved to be sensitive as well. Joseph et al[52] how-
ever, reported that although test was 100% specific, the 
test was only 66% sensitive. Pill et al[53] reported similar 
results. It is unfortunate indeed that no illustrations of  
false negative studies, the salient point of  these investiga-
tions, were provided in either publication. 
There are some data that indicate performing WBC 
imaging at more than one time point could obviate the 
need for marrow imaging. The hypothesis is that images 
acquired shortly after injection represent marrow while 
images acquired later represent infection. Difference in 
uptake patterns over time is indicative of  infection. The 
accuracy of  the test improved from about 75% when im-
ages were interpreted visually, to about 95% when semi-
quantitative analysis was performed[54].
There are, unfortunately, disadvantages to WBC/
marrow imaging. The leukocyte labeling procedure is 
demanding, not routinely available, and involves contact 
with blood products. Labeling enough leukocytes to pro-
duce diagnostically useful studies can be difficult in im-
munocompromised individuals. Image quality, especially 
when using indium-111, is not ideal. The need to perform 
marrow imaging is another disadvantage. Radiolabeled 
antigranulocyte antibodies and antibody fragments have 
been explored as alternatives.
Besilesomab is a murine monoclonal G1 immuno-
globulin that binds to Normal Cross-reactive Antigen-95 
on leukocytes[55]. Using visual image analysis the sensitiv-
ity and specificity for joint replacement infection range 
from 67%-91% and 57%-75%, respectively. By perform-
ing complementary bone imaging or semiquantitative 
analysis, sensitivity ranged from 67% to 100%; specificity 
ranged from 84% to 100%[56-59]. 
Sulesomab is a fragment antigen binding (Fab’) por-
tion of  a murine monoclonal G1 immunoglobulin that 
binds to Nonspecific Cross-reactive Antigen-90 on leuko-
cytes[55]. Reported sensitivity and specificity for prosthetic 
joint infection have ranged from 75% to 93% and 65% to 
86%, respectively[60-62]. Dual time point imaging and time 
activity curve analysis may improve test accuracy[63-65]. 
Somewhat surprisingly, even though in-vivo labeled 
leukocytes accumulate in the marrow, in much the same 
way that in-vitro labeled leukocytes do, scant attention has 
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A B
Figure 8  Aseptically loosened left knee arthroplasty. A: On this anterior image from an indium-111 labeled leukocyte study, there is intense periprosthetic activity 
around both the tibial and femoral components (arrows), while there is no activity around the contralateral knee.  The study could be interpreted erroneously as posi-
tive for infection. Compare the intensity of activity around this prosthesis with the intensity of activity around the infected hip arthroplasty in Figure 7A. As these two 
cases illustrate, the intensity of labeled leukocyte activity around a prosthetic joint is not a reliable criterion for determining the presence or absence of infection; B: 
The distribution of periprosthetic activity on the labeled leukocyte (left, 111In-WBC) and sulfur colloid bone marrow (right, 99mTc-SC) images is virtually identical (spatially 
congruent) and the combined study is negative for infection. The periprosthetic activity on the labeled leukocyte image is due to marrow, not to infection. Performing 
complementary bone marrow imaging eliminates the two major difficulties inherent in the interpretation of labeled leukocyte images: variable intensity of periprosthetic 
activity and differentiating bone marrow activity from infection. Same patient illustrated in Figure 8A.
been paid to combining these studies with bone marrow 
imaging. In one of  the few investigations in which com-
plementary bone marrow imaging was performed, Sousa 
et al[66] reported that the specificity of  99mTc-sulesomab 
increased from 20% to 100%, when complementary mar-
row imaging was performed.   
Using in-vivo labeled leukocytes overcomes the limita-
tions of  the in-vitro labeling procedure. Based on pub-
lished data however, an additional study, either bone or 
marrow imaging probably still needs to be performed. 
Furthermore, besilesomab, which is a murine antibody, 
incites a human antimurine antibody (HAMA) response 
in up to 30% of  patients[57]. Patients should be screened 
for HAMA and a positive result is a contraindication to 
the procedure. Because of  immunogenicity concerns, pa-
tients should not undergo repeat studies with this agent. 
Not surprisingly, in-vivo labeled WBC imaging, using anti-
granulocyte antibodies, has not gained wide acceptance in 
the diagnostic workup of  the painful joint replacement. 
18F-fluorodeoxyglucose 
18F-fluorodeoxyglucose (FDG) is transported into cells 
via glucose transporters and phosphorylated to 18F-2’-
FDG-6 phosphate but is not metabolized. FDG uptake 
depends on cellular metabolic rate and the number of  
glucose transporters. Activated leukocytes demonstrate 
increased expression of  these transporters with increased 
affinity for FDG in the presence of  cytokines and growth 
factors. There are several advantages to FDG. The proce-
dure is completed within two hours after injection. Target 
to background ratio is high. Images obtained with posi-
tron emission tomography (PET) have much higher reso-
lution than those obtained with conventional agents[67].
Several investigators have studied the role of  FDG-
PET for evaluating painful lower extremity joint pros-
theses. Zhuang et al[68] evaluated 74 lower extremity joint 
prostheses and reported that increased activity along 
the bone prosthesis interface was 89.5% and 77.8 % for 
diagnosing infection of  hip and knee arthroplasties, re-
spectively. Accuracy depended on location, not intensity, 
of  FDG uptake. Using similar criteria Chacko et al[69] re-
ported that the test was 92% sensitive and 97% specific 
for hip replacement infection. Infection could not be dif-
ferentiated from aseptic loosening based on intensity of  
periprosthetic uptake. 
Reinartz et al[29] studied 92 hip prostheses with three 
phase bone scintigraphy and FDG-PET. Sensitivity, 
specificity and accuracy of  three phase bone scintigraphy 
were 68%, 76% and 74% vs 94%, 95%, and 95%, respec-
tively, for FDG-PET. Activity around the acetabular com-
ponent and proximal aspect of  the femoral component 
on FDG-PET images was not associated with infection. 
Pattern, but not intensity, of  periprosthetic uptake was 
useful for differentiating infection from aseptic loosening. 
Cremerius et al[70] reported that FDG was 89% accurate 
for hip replacement infection. Gravius et al[71] reported 
similar results. Pill et al[53] studied 92 painful hip prosthe-
ses, including 21 infected devices, and reported that FDG 
was 95% sensitive and 93% specific for diagnosing infec-
tion. Fifty one of  the prostheses, including ten infected 
devices, also were studied with WBC/marrow imaging. 
The sensitivity and specificity of  WBC/marrow imaging 
in this subgroup were 50% and 95.1%, respectively. 
Manthey et al[72] reported that FDG was 96% accurate 
for prosthetic joint infection. They also reported that ac-
tivity around the femoral head and neck indicated syno-
vitis plus infection, observations that contradict those of  
previous investigations[68,69]. 
Stumpe et al[30] observed that, in patients with painful 
hip replacements, intense bone prosthesis interface activ-
ity was reasonably specific (81% for reader 1 and 85% for 
reader 2), but not sensitive (33% for reader 1, 56% for 
reader 2) for diagnosing infection (33% for reader 1, 56% 
for reader 2). The accuracy of  the test, for both read-
ers, was 69%. Bone scintigraphy was more accurate than 
FDG-PET (80% vs 69%) in this investigation.
Van Acker et al[73] studied 21 patients with suspected 
prosthetic knee infection. FDG-PET was 100% sensitive 
and 73% specific. Sensitivity and specificity of  WBC/
bone imaging was 100% and 93%, respectively. Vanquick-
enborne et al[74] reported similar results. 
García-Barrecheguren et al[75] studied 24 hip replace-
ments. FDG-PET was neither sensitive (64%) nor specif-
ic (67%) for infection. Delank et al[76] studied 27 patients 
with failed hip and knee replacements and concluded 
that FDG-PET could not reliably differentiate between 
infection and aseptic inflammation.
Love et al[50] evaluated 59 failed lower extremity joint 
prostheses with FDG-PET and WBC/marrow imaging. 
Among the criteria used for image interpretation, bone 
prosthesis interface activity, with a target to background 
ratio greater than 3.6 for hip replacements and 3.1 for 
knee replacements was the most accurate (71%) for diag-
nosing infection. The accuracy of  WBC/marrow imag-
ing, in contrast, was 95%.
In a met analysis sensitivity and specificity of  FDG-
PET for prosthetic joint infection were 82% and 87% re-
spectively[77]. In view of  the large number of  inconsistent 
and contradictory results that have been reported to date, 
the place of  FDG-PET in the assessment of  the pros-
thetic joint remains to be determined.
Infection-specific tracers 
Given the dramatic differences in the management of  
aseptic loosening and infection of  prostheses, the im-
portance of  accurately differentiating between these two 
conditions cannot be overstated. The development of  an 
infection specific imaging agent would be a welcome im-
provement over the current procedures.
The potential of  radiolabeled antibiotics as “infection-
specific” radiopharmaceuticals has been explored. The 
hypothesis is that the radiolabeled antibiotic enters, and is 
metabolized by, bacteria and could be used to accurately 
localize infection. Although the results of  initial stud-
ies were encouraging, subsequent investigations raised 
significant doubts about the validity of  this concept and 
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enthusiasm for radiolabeled antibiotics has faded[78-81].
Antimicrobial peptides bind to the bacterial cell mem-
brane. Their expression may be constant or induced on 
contact with microbes. They also can be transported via 
leukocytes[82]. 99mTc-UBI 29-41, a radiolabeled synthetic 
fragment of  the naturally occurring human antimicrobial 
peptide ubiquicidin, appears to be able to differentiate 
between infection and sterile inflammation[83]. Recent 
data suggest that this agent is both sensitive and specific 
for prosthetic joint infection[84,85].
FUTURE
Initial data suggest that single-photon emission computed 
tomography (SPECT)/electronic computer X-ray tomog-
raphy technique (CT) may contribute useful information 
to the evaluation of  the failed joint arthroplasty. For 
example, nuclear arthrography often is performed as a 
dual isotope procedure, in which the bone scan provides 
“anatomic detail” and another radiopharmaceutical, often 
an indium-111 labeled complex, is used for the arthro-
graphic component. A potential alternative to the dual 
isotope technique is SPECT/CT arthrography, in which 
the CT component provides the anatomic landmarks 
necessary for radiopharmaceutical localization. In one in-
vestigation SPECT/CT was significantly better than pla-
nar imaging for the acetabular cup of  hip prostheses[86]. 
For knee arthroplasties, SPECT/CT offered a significant 
improvement over planar imaging for detecting femoral 
component loosening. SPECT/CT also was better than 
planar imaging for detecting tibial component loosening 
but statistical significance was not reached.
Hirschmann et al[87] reported that SPECT/CT could 
detect mechanical loosening, joint instability, component 
malposition, and patellofemoral problems in patients with 
knee arthroplasties. In another investigation of  knee ar-
throplasties, SPECT/CT significantly altered the working 
diagnosis and proposed treatment, and changed the initial 
intention to revise or treat the patients non-surgically. 
The diagnosis made with SPECT/CT was correct in all 
patients who underwent surgery[88].
Graute et al[89] evaluated the contribution of  SPECT/
CT as an adjunct to planar scintigraphy with 99mTc-besile-
somab for diagnosing and localizing low-grade prosthetic 
joint infection. Planar imaging was 66% sensitive, and 
60% specific for infection. Combining planar imaging 
with SPECT/CT, sensitivity and specificity improved to 
89% and 73%, respectively. 
The potential impact of  SPECT/CT extends well 
beyond diagnosing infection. In patients with a positive 
study, for example, the examination could provide infor-
mation about the extent of  infection as well as other ab-
normalities involving the native bone and the prosthesis 
(Figure 7C-E); joint aspiration and culture could be per-
formed at the same time. In patients with negative studies 
the CT component could provide information about oth-
er causes of  prosthetic failure. In such a scenario patients 
would be spared the need to undergo multiple imaging 
tests at different times and possibly different locations, 
and a diagnosis could be made more expeditiously. 
Flourine18-fluoride-PET (fluoride-PET) bone im-
aging shows great promise in the evaluation of  joint 
arthroplasties. Some investigators have used this test in 
a manner analogous to that of  conventional bone scin-
tigraphy. Sterner et al[90] compared the results of  fluoride-
PET bone scans to plain radiographs in 14 patients with 
painful knee arthroplasties. Sensitivity, specificity, and 
accuracy of  the fluoride PET study for detecting aseptic 
loosening were 100%, 56%, and 71%, respectively. Sensi-
tivity, specificity, and accuracy of  plain radiographs were 
43%, 86%, and 64%, respectively. 
Other investigators have explored the potential of  flu-
oride-PET for studying bone metabolism. An important 
concern in patients undergoing hip resurfacing arthro-
plasty is the viability of  the remaining femoral head, and 
the risk of  postoperative fracture or avascular necrosis. 
Conventional radiographs are of  limited utility, because 
the femoral head is obscured by the overlying metallic 
components of  the device. Ullmark et al[91] reported that 
fluoride PET correctly identified aseptic necrosis in three 
of  fourteen patients with a hip resurfacing arthroplasty. 
Radiographs were negative in all cases. These investiga-
tors concluded that fluoride-PET is useful for evaluating 
bone metabolism at resurfacing arthroplasty. In another 
investigation, Ullmark et al[92] studied bone mineralization 
around the femoral component of  cementless hip arthro-
plasties. They concluded that fluoride-PET is a valuable 
tool for analysis of  bone mineralization patterns around 
uncemented femoral stems and together with the modi-
fied Polar Map system could be useful to study metabolic 
bone responses to prosthetic implants.
There are recent data that suggest that Fluoride-PET 
is a valuable tool to analyse bone formation and second-
ary stabilization of  a press-fit acetabular cup in patients 
undergoing total hip arthroplasty[93].
CONCLUSION
At the moment, nuclear medicine is most valuable for 
determining whether or not a painful joint prosthesis is 
infected. WBC/marrow imaging, currently, is the best 
available imaging test for this purpose. Preliminary data 
suggest that SPECT/CT, in addition to providing infor-
mation about the presence and extent of  infection, may 
be able to provide additional information about other 
conditions that cause joint replacements to fail. Fluoride-
PET also may provide hitherto unknown insight into 
periprosthetic bone metabolism.  
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